CV Advisors »

C4 Therapeutics shares owned by CV Advisors

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by CV Advisors from 13F filings

Historical chart of CV Advisors investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by CV Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by CV Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $304k 65k 4.67

More positions owned by CV Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Applied Materials (AMAT)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Janus Detroit Str Tr B-bbb Clo Etf (JBBB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Broadcom (AVGO)

View all positions for CV Advisors

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
BlackRock
Squadron Capital Management
Lynx1 Capital Management
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Citadel Advisors
Goldman Sachs Group
Daniel D. Thurber
Two Sigma Investments
Soleus Capital Management
Silverarc Capital Management
Bank of America Corporation

View all funds holding C4 Therapeutics